Pharmaceutical Suppositories Market By Type (Rectal Suppositories, Vaginal Suppositories), By Base (Fatty Bases, Water Miscible Base, Emulsifying Bases), By Prescription Type (OTC, Prescribed Suppositories), By Therapeutic Application (Analgesics and Anti-Inflammatory Drugs, Antiemetics, Laxatives, Hormonal Therapies, Antifungals and Antibacterials, Others), By Fill Volume Categories (Small Fill Volumes, Medium Fill Volumes, Large Fill Volumes), By Age Group (Pediatric Use, Adult Use), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers), By End User (Hospitals and Clinics, Home Care , Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.
Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.
The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies’ efforts to raise public awareness of suppository benefits, further support market growth.
However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.
The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Prescription Type
OTC
Prescribed Suppositories
By Therapeutic Application
Analgesics and Anti-Inflammatory Drugs
Antiemetics
Laxatives
Hormonal Therapies
Antifungals and Antibacterials
Others
By Fill Volume Categories
Small Fill Volumes
Medium Fill Volumes
Large Fill Volumes
By Type
Rectal Suppositories
Vaginal Suppositories
By Age Group
Pediatric Use
Adult Use
By Base
Fatty Bases
Water Miscible Base
Type
Glycero Gelatin Base
Soap Glycerin Suppositories
Polyethylene Glycol Bases
Emulsifying Bases
Type
Witepsol
Massa Esterium
Massuppol
By Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers
By End User
Hospitals and Clinics
Home Care
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East And Africa
Key Market Players
Bausch Health Companies Inc.
Bayer AG
Bliss GVS Pharma Ltd
Church & Dwight Co. Inc.
Cosette Pharmaceuticals, Inc.
Intas Pharmaceuticals Ltd.
Novartis AG
Pfizer Inc.
Sanofi S.A.
Zydus Lifesciences Limited
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of acute & chronic disorders
- 3.4.1.2. Increase in the geriatric population
- 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
- 3.4.2. Restraints
- 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
- 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
- 3.4.3. Opportunities
- 3.4.3.1. Technological advancements in formulation technology
- CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Rectal Suppositories
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Vaginal Suppositories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Fatty Bases
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Water Miscible Base
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
- 5.4. Emulsifying Bases
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type
- CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. OTC
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Prescribed Suppositories
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Analgesics and Anti-Inflammatory Drugs
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Antiemetics
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Laxatives
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Hormonal Therapies
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
- 7.6. Antifungals and Antibacterials
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country
- 7.7. Others
- 7.7.1. Key market trends, growth factors and opportunities
- 7.7.2. Market size and forecast, by region
- 7.7.3. Market share analysis by country
- CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES
- 8.1. Overview
- 8.1.1. Market size and forecast
- 8.2. Small Fill Volumes
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
- 8.3. Medium Fill Volumes
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country
- 8.4. Large Fill Volumes
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by region
- 8.4.3. Market share analysis by country
- CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP
- 9.1. Overview
- 9.1.1. Market size and forecast
- 9.2. Pediatric Use
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by region
- 9.2.3. Market share analysis by country
- 9.3. Adult Use
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by region
- 9.3.3. Market share analysis by country
- CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
- 10.1. Overview
- 10.1.1. Market size and forecast
- 10.2. Hospital Pharmacies
- 10.2.1. Key market trends, growth factors and opportunities
- 10.2.2. Market size and forecast, by region
- 10.2.3. Market share analysis by country
- 10.3. Drug Stores and Retail Pharmacies
- 10.3.1. Key market trends, growth factors and opportunities
- 10.3.2. Market size and forecast, by region
- 10.3.3. Market share analysis by country
- 10.4. Online Providers
- 10.4.1. Key market trends, growth factors and opportunities
- 10.4.2. Market size and forecast, by region
- 10.4.3. Market share analysis by country
- CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
- 11.1. Overview
- 11.1.1. Market size and forecast
- 11.2. Hospitals and Clinics
- 11.2.1. Key market trends, growth factors and opportunities
- 11.2.2. Market size and forecast, by region
- 11.2.3. Market share analysis by country
- 11.3. Home Care
- 11.3.1. Key market trends, growth factors and opportunities
- 11.3.2. Market size and forecast, by region
- 11.3.3. Market share analysis by country
- 11.4. Others
- 11.4.1. Key market trends, growth factors and opportunities
- 11.4.2. Market size and forecast, by region
- 11.4.3. Market share analysis by country
- CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
- 12.1. Overview
- 12.1.1. Market size and forecast By Region
- 12.2. North America
- 12.2.1. Key market trends, growth factors and opportunities
- 12.2.2. Market size and forecast, by Type
- 12.2.3. Market size and forecast, by Base
- 12.2.4. Market size and forecast, by Prescription Type
- 12.2.5. Market size and forecast, by Therapeutic Application
- 12.2.6. Market size and forecast, by Fill Volume Categories
- 12.2.7. Market size and forecast, by Age Group
- 12.2.8. Market size and forecast, by Distribution Channel
- 12.2.9. Market size and forecast, by End User
- 12.2.10. Market size and forecast, by country
- 12.2.10.1. U.S.
- 12.2.10.1.1. Market size and forecast, by Type
- 12.2.10.1.2. Market size and forecast, by Base
- 12.2.10.1.3. Market size and forecast, by Prescription Type
- 12.2.10.1.4. Market size and forecast, by Therapeutic Application
- 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.1.6. Market size and forecast, by Age Group
- 12.2.10.1.7. Market size and forecast, by Distribution Channel
- 12.2.10.1.8. Market size and forecast, by End User
- 12.2.10.2. Canada
- 12.2.10.2.1. Market size and forecast, by Type
- 12.2.10.2.2. Market size and forecast, by Base
- 12.2.10.2.3. Market size and forecast, by Prescription Type
- 12.2.10.2.4. Market size and forecast, by Therapeutic Application
- 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.2.6. Market size and forecast, by Age Group
- 12.2.10.2.7. Market size and forecast, by Distribution Channel
- 12.2.10.2.8. Market size and forecast, by End User
- 12.2.10.3. Mexico
- 12.2.10.3.1. Market size and forecast, by Type
- 12.2.10.3.2. Market size and forecast, by Base
- 12.2.10.3.3. Market size and forecast, by Prescription Type
- 12.2.10.3.4. Market size and forecast, by Therapeutic Application
- 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.3.6. Market size and forecast, by Age Group
- 12.2.10.3.7. Market size and forecast, by Distribution Channel
- 12.2.10.3.8. Market size and forecast, by End User
- 12.3. Europe
- 12.3.1. Key market trends, growth factors and opportunities
- 12.3.2. Market size and forecast, by Type
- 12.3.3. Market size and forecast, by Base
- 12.3.4. Market size and forecast, by Prescription Type
- 12.3.5. Market size and forecast, by Therapeutic Application
- 12.3.6. Market size and forecast, by Fill Volume Categories
- 12.3.7. Market size and forecast, by Age Group
- 12.3.8. Market size and forecast, by Distribution Channel
- 12.3.9. Market size and forecast, by End User
- 12.3.10. Market size and forecast, by country
- 12.3.10.1. Germany
- 12.3.10.1.1. Market size and forecast, by Type
- 12.3.10.1.2. Market size and forecast, by Base
- 12.3.10.1.3. Market size and forecast, by Prescription Type
- 12.3.10.1.4. Market size and forecast, by Therapeutic Application
- 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.1.6. Market size and forecast, by Age Group
- 12.3.10.1.7. Market size and forecast, by Distribution Channel
- 12.3.10.1.8. Market size and forecast, by End User
- 12.3.10.2. France
- 12.3.10.2.1. Market size and forecast, by Type
- 12.3.10.2.2. Market size and forecast, by Base
- 12.3.10.2.3. Market size and forecast, by Prescription Type
- 12.3.10.2.4. Market size and forecast, by Therapeutic Application
- 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.2.6. Market size and forecast, by Age Group
- 12.3.10.2.7. Market size and forecast, by Distribution Channel
- 12.3.10.2.8. Market size and forecast, by End User
- 12.3.10.3. UK
- 12.3.10.3.1. Market size and forecast, by Type
- 12.3.10.3.2. Market size and forecast, by Base
- 12.3.10.3.3. Market size and forecast, by Prescription Type
- 12.3.10.3.4. Market size and forecast, by Therapeutic Application
- 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.3.6. Market size and forecast, by Age Group
- 12.3.10.3.7. Market size and forecast, by Distribution Channel
- 12.3.10.3.8. Market size and forecast, by End User
- 12.3.10.4. Rest of Europe
- 12.3.10.4.1. Market size and forecast, by Type
- 12.3.10.4.2. Market size and forecast, by Base
- 12.3.10.4.3. Market size and forecast, by Prescription Type
- 12.3.10.4.4. Market size and forecast, by Therapeutic Application
- 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.4.6. Market size and forecast, by Age Group
- 12.3.10.4.7. Market size and forecast, by Distribution Channel
- 12.3.10.4.8. Market size and forecast, by End User
- 12.4. Asia-Pacific
- 12.4.1. Key market trends, growth factors and opportunities
- 12.4.2. Market size and forecast, by Type
- 12.4.3. Market size and forecast, by Base
- 12.4.4. Market size and forecast, by Prescription Type
- 12.4.5. Market size and forecast, by Therapeutic Application
- 12.4.6. Market size and forecast, by Fill Volume Categories
- 12.4.7. Market size and forecast, by Age Group
- 12.4.8. Market size and forecast, by Distribution Channel
- 12.4.9. Market size and forecast, by End User
- 12.4.10. Market size and forecast, by country
- 12.4.10.1. Japan
- 12.4.10.1.1. Market size and forecast, by Type
- 12.4.10.1.2. Market size and forecast, by Base
- 12.4.10.1.3. Market size and forecast, by Prescription Type
- 12.4.10.1.4. Market size and forecast, by Therapeutic Application
- 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.1.6. Market size and forecast, by Age Group
- 12.4.10.1.7. Market size and forecast, by Distribution Channel
- 12.4.10.1.8. Market size and forecast, by End User
- 12.4.10.2. China
- 12.4.10.2.1. Market size and forecast, by Type
- 12.4.10.2.2. Market size and forecast, by Base
- 12.4.10.2.3. Market size and forecast, by Prescription Type
- 12.4.10.2.4. Market size and forecast, by Therapeutic Application
- 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.2.6. Market size and forecast, by Age Group
- 12.4.10.2.7. Market size and forecast, by Distribution Channel
- 12.4.10.2.8. Market size and forecast, by End User
- 12.4.10.3. India
- 12.4.10.3.1. Market size and forecast, by Type
- 12.4.10.3.2. Market size and forecast, by Base
- 12.4.10.3.3. Market size and forecast, by Prescription Type
- 12.4.10.3.4. Market size and forecast, by Therapeutic Application
- 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.3.6. Market size and forecast, by Age Group
- 12.4.10.3.7. Market size and forecast, by Distribution Channel
- 12.4.10.3.8. Market size and forecast, by End User
- 12.4.10.4. Rest of Asia-Pacific
- 12.4.10.4.1. Market size and forecast, by Type
- 12.4.10.4.2. Market size and forecast, by Base
- 12.4.10.4.3. Market size and forecast, by Prescription Type
- 12.4.10.4.4. Market size and forecast, by Therapeutic Application
- 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.4.6. Market size and forecast, by Age Group
- 12.4.10.4.7. Market size and forecast, by Distribution Channel
- 12.4.10.4.8. Market size and forecast, by End User
- 12.5. LAMEA
- 12.5.1. Key market trends, growth factors and opportunities
- 12.5.2. Market size and forecast, by Type
- 12.5.3. Market size and forecast, by Base
- 12.5.4. Market size and forecast, by Prescription Type
- 12.5.5. Market size and forecast, by Therapeutic Application
- 12.5.6. Market size and forecast, by Fill Volume Categories
- 12.5.7. Market size and forecast, by Age Group
- 12.5.8. Market size and forecast, by Distribution Channel
- 12.5.9. Market size and forecast, by End User
- 12.5.10. Market size and forecast, by country
- 12.5.10.1. Latin America
- 12.5.10.1.1. Market size and forecast, by Type
- 12.5.10.1.2. Market size and forecast, by Base
- 12.5.10.1.3. Market size and forecast, by Prescription Type
- 12.5.10.1.4. Market size and forecast, by Therapeutic Application
- 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.5.10.1.6. Market size and forecast, by Age Group
- 12.5.10.1.7. Market size and forecast, by Distribution Channel
- 12.5.10.1.8. Market size and forecast, by End User
- 12.5.10.2. Middle East And Africa
- 12.5.10.2.1. Market size and forecast, by Type
- 12.5.10.2.2. Market size and forecast, by Base
- 12.5.10.2.3. Market size and forecast, by Prescription Type
- 12.5.10.2.4. Market size and forecast, by Therapeutic Application
- 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.5.10.2.6. Market size and forecast, by Age Group
- 12.5.10.2.7. Market size and forecast, by Distribution Channel
- 12.5.10.2.8. Market size and forecast, by End User
- CHAPTER 13: COMPETITIVE LANDSCAPE
- 13.1. Introduction
- 13.2. Top winning strategies
- 13.3. Product mapping of top 10 player
- 13.4. Competitive dashboard
- 13.5. Competitive heatmap
- 13.6. Top player positioning, 2023
- CHAPTER 14: COMPANY PROFILES
- 14.1. Intas Pharmaceuticals Ltd.
- 14.1.1. Company overview
- 14.1.2. Key executives
- 14.1.3. Company snapshot
- 14.1.4. Operating business segments
- 14.1.5. Product portfolio
- 14.2. Pfizer Inc.
- 14.2.1. Company overview
- 14.2.2. Key executives
- 14.2.3. Company snapshot
- 14.2.4. Operating business segments
- 14.2.5. Product portfolio
- 14.2.6. Business performance
- 14.3. Church & Dwight Co. Inc.
- 14.3.1. Company overview
- 14.3.2. Key executives
- 14.3.3. Company snapshot
- 14.3.4. Operating business segments
- 14.3.5. Product portfolio
- 14.3.6. Business performance
- 14.4. Zydus Lifesciences Limited
- 14.4.1. Company overview
- 14.4.2. Key executives
- 14.4.3. Company snapshot
- 14.4.4. Operating business segments
- 14.4.5. Product portfolio
- 14.4.6. Business performance
- 14.4.7. Key strategic moves and developments
- 14.5. Bayer AG
- 14.5.1. Company overview
- 14.5.2. Key executives
- 14.5.3. Company snapshot
- 14.5.4. Operating business segments
- 14.5.5. Product portfolio
- 14.5.6. Business performance
- 14.6. Novartis AG
- 14.6.1. Company overview
- 14.6.2. Key executives
- 14.6.3. Company snapshot
- 14.6.4. Operating business segments
- 14.6.5. Product portfolio
- 14.6.6. Business performance
- 14.7. Sanofi S.A.
- 14.7.1. Company overview
- 14.7.2. Key executives
- 14.7.3. Company snapshot
- 14.7.4. Operating business segments
- 14.7.5. Product portfolio
- 14.7.6. Business performance
- 14.8. Bliss GVS Pharma Ltd
- 14.8.1. Company overview
- 14.8.2. Key executives
- 14.8.3. Company snapshot
- 14.8.4. Operating business segments
- 14.8.5. Product portfolio
- 14.8.6. Business performance
- 14.9. Bausch Health Companies Inc.
- 14.9.1. Company overview
- 14.9.2. Key executives
- 14.9.3. Company snapshot
- 14.9.4. Operating business segments
- 14.9.5. Product portfolio
- 14.9.6. Business performance
- 14.10. Cosette Pharmaceuticals, Inc.
- 14.10.1. Company overview
- 14.10.2. Key executives
- 14.10.3. Company snapshot
- 14.10.4. Operating business segments
- 14.10.5. Product portfolio
- LIST OF TABLES
- TABLE 01. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 02. PHARMACEUTICAL SUPPOSITORIES MARKET FOR RECTAL SUPPOSITORIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 03. PHARMACEUTICAL SUPPOSITORIES MARKET FOR VAGINAL SUPPOSITORIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 04. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 05. PHARMACEUTICAL SUPPOSITORIES MARKET FOR FATTY BASES, BY REGION, 2023-2035 ($MILLION)
- TABLE 06. PHARMACEUTICAL SUPPOSITORIES MARKET FOR WATER MISCIBLE BASE, BY REGION, 2023-2035 ($MILLION)
- TABLE 07. GLOBAL WATER MISCIBLE BASE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 08. PHARMACEUTICAL SUPPOSITORIES MARKET FOR EMULSIFYING BASES, BY REGION, 2023-2035 ($MILLION)
- TABLE 09. GLOBAL EMULSIFYING BASES PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 10. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 11. PHARMACEUTICAL SUPPOSITORIES MARKET FOR OTC, BY REGION, 2023-2035 ($MILLION)
- TABLE 12. PHARMACEUTICAL SUPPOSITORIES MARKET FOR PRESCRIBED SUPPOSITORIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 13. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 14. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ANALGESICS AND ANTI-INFLAMMATORY DRUGS, BY REGION, 2023-2035 ($MILLION)
- TABLE 15. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ANTIEMETICS, BY REGION, 2023-2035 ($MILLION)
- TABLE 16. PHARMACEUTICAL SUPPOSITORIES MARKET FOR LAXATIVES, BY REGION, 2023-2035 ($MILLION)
- TABLE 17. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HORMONAL THERAPIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 18. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ANTIFUNGALS AND ANTIBACTERIALS, BY REGION, 2023-2035 ($MILLION)
- TABLE 19. PHARMACEUTICAL SUPPOSITORIES MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
- TABLE 20. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 21. PHARMACEUTICAL SUPPOSITORIES MARKET FOR SMALL FILL VOLUMES, BY REGION, 2023-2035 ($MILLION)
- TABLE 22. PHARMACEUTICAL SUPPOSITORIES MARKET FOR MEDIUM FILL VOLUMES, BY REGION, 2023-2035 ($MILLION)
- TABLE 23. PHARMACEUTICAL SUPPOSITORIES MARKET FOR LARGE FILL VOLUMES, BY REGION, 2023-2035 ($MILLION)
- TABLE 24. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 25. PHARMACEUTICAL SUPPOSITORIES MARKET FOR PEDIATRIC USE, BY REGION, 2023-2035 ($MILLION)
- TABLE 26. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ADULT USE, BY REGION, 2023-2035 ($MILLION)
- TABLE 27. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 28. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 29. PHARMACEUTICAL SUPPOSITORIES MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2023-2035 ($MILLION)
- TABLE 30. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ONLINE PROVIDERS, BY REGION, 2023-2035 ($MILLION)
- TABLE 31. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 32. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2023-2035 ($MILLION)
- TABLE 33. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOME CARE , BY REGION, 2023-2035 ($MILLION)
- TABLE 34. PHARMACEUTICAL SUPPOSITORIES MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
- TABLE 35. PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2023-2035 ($MILLION)
- TABLE 36. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 37. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 38. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 39. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 40. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 41. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 42. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 43. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 44. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 45. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 46. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 47. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 48. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 49. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 50. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 51. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 52. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 53. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 54. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 55. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 56. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 57. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 58. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 59. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 60. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 61. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 62. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 63. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 64. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 65. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 66. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 67. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 68. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 69. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 70. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 71. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 72. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 73. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 74. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 75. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 76. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 77. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 78. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 79. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 80. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 81. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 82. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 83. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 84. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 85. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 86. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 87. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 88. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 89. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 90. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 91. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 92. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 93. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 94. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 95. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 96. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 97. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 98. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 99. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 100. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 101. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 102. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 103. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 104. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 105. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 106. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 107. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 108. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 109. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 110. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 111. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 112. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 113. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 114. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
- TABLE 115. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP, 2023-2035 ($MILLION)
- TABLE 116. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
- TABLE 117. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2023-2035 ($MILLION)
- TABLE 118. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 119. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 120. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2023-2035 ($MILLION)
- TABLE 121. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2023-2035 ($MILLION)
- TABLE 122. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION, 2023-2035 ($MILLION)
- TABLE 123. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES, 2023-2035 ($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook